Can captopril influence the formation of malignant ascites?
van Heest
Florien
F
Department of Family Medicine, University of Groningen, Netherlands.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001201:Ascites / Q000188:drug therapy* / Q000473:pathology; D002216:Captopril / Q000627:therapeutic use*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged
D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril